GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes ; day:3 ; month:6 ; year:2024 ; pages:1-10
Acta diabetologica ; (3.6.2024), 1-10
- Urheber
-
Ciardullo, Stefano
Morieri, Mario Luca
Daniele, Giuseppe
Fiorentino, Teresa Vanessa
Mezza, Teresa
Tricò, Domenico
Consoli, Agostino
Prato, Stefano Del
Giorgino, Francesco
Piro, Salvatore
Solini, Anna
Avogaro, Angelo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00592-024-02300-6
- URN
-
urn:nbn:de:101:1-2408102129115.421755758145
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ciardullo, Stefano
- Morieri, Mario Luca
- Daniele, Giuseppe
- Fiorentino, Teresa Vanessa
- Mezza, Teresa
- Tricò, Domenico
- Consoli, Agostino
- Prato, Stefano Del
- Giorgino, Francesco
- Piro, Salvatore
- Solini, Anna
- Avogaro, Angelo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future
Effects of GLP-1 receptor agonists on neurological complications of diabetes
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes
Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Novel Ghrelin receptor agonists and inverse agonists to alter energy homeostasis
Leitung GIP
Discovering allatostatin type-C receptor specific agonists
Jahresberichte des GIP
Schriftwechsel des GIP
Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future
Effects of GLP-1 receptor agonists on neurological complications of diabetes
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes
Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Novel Ghrelin receptor agonists and inverse agonists to alter energy homeostasis
Leitung GIP
Discovering allatostatin type-C receptor specific agonists
Jahresberichte des GIP
Schriftwechsel des GIP
Spatiotemporal GLP-1 and GIP Receptor Signaling and Trafficking/Recycling Dynamics Induced by Selected Receptor Mono- and Dual-agonists
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future
Effects of GLP-1 receptor agonists on neurological complications of diabetes
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
Finerenone attenuates downregulation of the kidney GLP-1 receptor and glucagon receptor and cardiac GIP receptor in mice with comorbid diabetes
Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Novel Ghrelin receptor agonists and inverse agonists to alter energy homeostasis
Leitung GIP
Discovering allatostatin type-C receptor specific agonists
Jahresberichte des GIP